RFK Jr.'s Potential FDA Role Sparks Concerns in Biotech and Health Sectors

With Donald Trump's election victory, there is speculation about the potential impact of his promise to give Robert F. Kennedy Jr. a significant role in his administration, particularly concerning the Food and Drug Administration (FDA). Trump's comments about letting RFK Jr. "go wild" on healthcare have raised concerns among public health experts about possible policy changes and disruptions at the FDA, which is responsible for ensuring the safety and efficacy of drugs and food in the U.S.